A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to demonstrate the efficacy of at least 1 dose of tapentadol IR 50 mg and/or 75 mg versus placebo using the sum of pain intensity difference at 48 hours (SPID48) to measure analgesic effect in Korean patients with acute pain following bunionectomy.
Epistemonikos ID: 32d497f483a3f7c39e04ebd17afae4b6d6a3dee6
First added on: May 10, 2024